|
Volumn 23, Issue 12, 2005, Pages 2586-2587
|
Rhabdomyosarcoma: Many similarities, a few philosophical differences
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RELAPSE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
EDITORIAL;
HEALTH PRACTITIONER;
HISTOPATHOLOGY;
HUMAN;
MEDICAL SOCIETY;
MORBIDITY;
PHILOSOPHY OF MEDICINE;
PRIORITY JOURNAL;
RADIATION DOSE;
RHABDOMYOSARCOMA;
SALVAGE THERAPY;
TOXICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
METHODOLOGY;
NOTE;
ORGANIZATION AND MANAGEMENT;
PATHOLOGY;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
ELIGIBILITY DETERMINATION;
HUMANS;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
RHABDOMYOSARCOMA;
SURVIVAL ANALYSIS;
|
EID: 18444369300
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.11.909 Document Type: Editorial |
Times cited : (63)
|
References (6)
|